Defining Clinical Supply Resilience

This segment of the Outsourced Pharma Live event, "Clinical Supply Therapy: Lowering Risk and Your Blood Pressure," addresses the true meaning of resilience in the clinical supply chain. The conversation explores how resilience involves building systems that absorb stress, establishing clear governance, and maintaining transparency to ensure the right supplies reach patients at the right time, without shifting pressure onto clinical sites. Featuring panelists Elisha Lowe, Founder and Principal at IRL Life Sciences Partners, and Steven A. Jacobs, President at Global BioPharm Solutions.